• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retirement Income Security Act of 1974 ("ERISA") (Brower Piven Release)

    6/11/24 11:52:13 AM ET
    $ATI
    $AWI
    $BMY
    $GE
    Steel/Iron Ore
    Industrials
    Plastic Products
    Industrials
    Get the next $ATI alert in real time by email

    BALTIMORE, June 11, 2024 (GLOBE NEWSWIRE) -- Lawsuits have been filed alleging that a number of large corporate employers have offloaded billions of dollars in pension obligations to Athene Annuity and Life Company and/or Athene Annuity & Life Assurance Company of New York, subsidiaries of Athene Holding Ltd. (collectively, "Athene") in violation of ERISA. In addition to AT&T Inc., Lockheed Martin Corporation, and Alcoa Corporation, against which lawsuits have already been filed, according to SEC filings and/or Athene's public statements, Bristol-Myers Squibb Company (NYSE:BMY), Armstrong World Industries, Inc. (NYSE:AWI), ATI, Inc. (NYSE:ATI), Weyerhaeuser Company (NYSE:WY), and General Electric (NYSE:GE) have offloaded pension obligations to Athene.  

    As these lawsuits allege, ERISA imposes strict fiduciary standards of conduct on employee pension plans, requiring fiduciaries to act with both prudence and loyalty and solely in the interest of employees who participate in the plan. The lawsuits allege breach of those duties to the detriment of some plan participants and beneficiaries, many of whom are former employees, by entering into transactions with Athene that removed those plan participants and beneficiaries from their employer's defined-benefit pension plans. The lawsuits allege that because of the transactions, plan participants and beneficiaries no longer enjoy certain benefits, including protection provided by the federally chartered Pension Benefit Guaranty Corporation. According to the lawsuits, the transactions have also harmed plan participants and beneficiaries by degrading the value of their pension benefits because of Athene's investment strategies that the lawsuits allege to be risky. The lawsuits also allege that the companies profited from their decision to offload pension obligations to Athene.

    If you are a former employee of any of the corporate employers mentioned in this release and have questions about your rights as they relate to the offloading of pension obligations, please email Charles Piven at [email protected] (referencing ERISA in the subject line) for more information.

    CONTACT:

    Brower Piven, A Professional Corporation

    Charles J. Piven, Esq.

    3704 North Charles Street

    Baltimore, MD 21218

    [email protected]



    Get the next $ATI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATI
    $AWI
    $BMY
    $GE

    CompanyDatePrice TargetRatingAnalyst
    GE Aerospace
    $GE
    4/1/2026$325.00Overweight
    Wells Fargo
    ATI Inc.
    $ATI
    4/1/2026$175.00Overweight
    Wells Fargo
    GE Aerospace
    $GE
    3/31/2026$301.00Neutral
    Daiwa Securities
    ATI Inc.
    $ATI
    3/25/2026$140.00Overweight
    KeyBanc Capital Markets
    Bristol-Myers Squibb Company
    $BMY
    2/25/2026$60.00Sector Perform
    RBC Capital Mkts
    GE Aerospace
    $GE
    2/20/2026$425.00Overweight
    Morgan Stanley
    Bristol-Myers Squibb Company
    $BMY
    2/20/2026$75.00Overweight
    Barclays
    ATI Inc.
    $ATI
    1/15/2026$141.00Overweight
    Alembic Global Advisors
    More analyst ratings

    $ATI
    $AWI
    $BMY
    $GE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 26, 2024 - FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia

    For Immediate Release: September 26, 2024 Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.   “Schizophrenia is a leading

    9/26/24 6:42:20 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 14, 2024 - FDA Roundup: June 14, 2024

    For Immediate Release: June 14, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a proposed exemption for certain cottage cheese products from the requirements of the Food Traceability Rule. The proposal would exempt Grade “A” cottage cheese that appears on the Interstate Milk Shippers List from the requirements of the r

    6/14/24 3:54:45 PM ET
    $MMSI
    $BMY
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    March 8, 2024 - FDA Roundup: March 8, 2024

    For Immediate Release: March 08, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced proposed new regulations to provide animal drug sponsors with predictable requirements for the labeling of prescription and over-the-counter new animal drugs, as well as new animal drugs for use in animal feeds. The proposed content and

    3/8/24 3:26:46 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ATI
    $AWI
    $BMY
    $GE
    SEC Filings

    View All

    SEC Form 10-Q filed by GE Aerospace

    10-Q - GENERAL ELECTRIC CO (0000040545) (Filer)

    4/21/26 6:36:02 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    GE Aerospace filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - GENERAL ELECTRIC CO (0000040545) (Filer)

    4/21/26 6:29:00 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    SEC Form DEFA14A filed by Bristol-Myers Squibb Company

    DEFA14A - BRISTOL MYERS SQUIBB CO (0000014272) (Filer)

    4/17/26 4:15:40 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ATI
    $AWI
    $BMY
    $GE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wells Fargo initiated coverage on GE Aerospace with a new price target

    Wells Fargo initiated coverage of GE Aerospace with a rating of Overweight and set a new price target of $325.00

    4/1/26 8:37:20 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    Wells Fargo initiated coverage on ATI Inc. with a new price target

    Wells Fargo initiated coverage of ATI Inc. with a rating of Overweight and set a new price target of $175.00

    4/1/26 8:21:42 AM ET
    $ATI
    Steel/Iron Ore
    Industrials

    Daiwa Securities initiated coverage on GE Aerospace with a new price target

    Daiwa Securities initiated coverage of GE Aerospace with a rating of Neutral and set a new price target of $301.00

    3/31/26 8:12:03 AM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    $ATI
    $AWI
    $BMY
    $GE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Winters Michael Carl

    4 - ARMSTRONG WORLD INDUSTRIES INC (0000007431) (Issuer)

    4/10/26 4:52:55 PM ET
    $AWI
    Plastic Products
    Industrials

    SEC Form 4 filed by Hershey Mark A

    4 - ARMSTRONG WORLD INDUSTRIES INC (0000007431) (Issuer)

    4/10/26 4:49:39 PM ET
    $AWI
    Plastic Products
    Industrials

    SEC Form 4 filed by Grizzle Victor

    4 - ARMSTRONG WORLD INDUSTRIES INC (0000007431) (Issuer)

    4/10/26 4:46:14 PM ET
    $AWI
    Plastic Products
    Industrials

    $ATI
    $AWI
    $BMY
    $GE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Foundation Medicine Expands Existing Collaboration with Bristol Myers Squibb to Develop a Next-Generation Sequencing Companion Diagnostic to Identify Patients with Homozygous MTAP Deletion

    Foundation Medicine, Inc., a global precision medicine company, today announced an expansion to its collaboration with Bristol Myers Squibb (NYSE:BMY) to develop FoundationOne®CDx as a next-generation sequencing-based companion diagnostic to identify patients with homozygous MTAP deletion in multiple indications for an investigational targeted therapy. The expansion broadens Foundation Medicine's longstanding relationship in advancing biomarker-driven therapies with Bristol Myers Squibb. Homozygous deletion is a major cause of MTAP deficiency.1 Copy number calling can have low signal-to-noise ratio, making the alterations challenging to accurately identify. FoundationOne CDx is a tissue-b

    4/21/26 7:00:00 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

    WALTHAM, Mass., April 20, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced the appointment of Felecia W. Ettenberg, a seasoned leader with more than 25 years of legal experience in the biopharmaceutical industry, as Chief Legal Officer (CLO). She will oversee Ardelyx's legal, compliance, regulatory, and government affairs operations. Ms. Ettenberg succeeds Elizabeth Grammer, who has chosen to retire after an extraordinary 16-year career at the company. "I am thrilled to welcome Felecia as our new Chief Legal Officer," said Mik

    4/20/26 8:00:00 AM ET
    $ARDX
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Starfighters Space Partners with Blackstar Orbital for Hypersonic Testing Platform as Space Sector Prepares for Historic SpaceX Public Debut

    CAPE CANAVERAL, Fla., April 15, 2026 (GLOBE NEWSWIRE) -- As SpaceX prepares for what could become the largest IPO in history with its confidential S-1 filing targeting a $1.75 trillion valuation and June roadshow, space infrastructure companies are positioning for sector-wide growth. Starfighters Space, Inc. (NYSE:FJET), owner and operator of the world's largest commercial supersonic aircraft fleet, has announced a strategic partnership with Blackstar Orbital to advance flight testing of revolutionary reusable hypersonic space systems. The March 26 Technical Interchange Agreement (TIA), unveiled at the Satellite 2026 conference, establishes a framework for integrating Blackstar's innovati

    4/15/26 10:44:18 AM ET
    $ASTS
    $FJET
    $GE
    Telecommunications Equipment
    Consumer Discretionary
    Air Freight/Delivery Services
    Consumer Electronics/Appliances

    $ATI
    $AWI
    $BMY
    $GE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Templin Roy W bought $99,998 worth of shares (575 units at $173.91), increasing direct ownership by 3% to 19,451 units (SEC Form 4)

    4 - ARMSTRONG WORLD INDUSTRIES INC (0000007431) (Issuer)

    3/2/26 5:47:08 PM ET
    $AWI
    Plastic Products
    Industrials

    Director O'Rourke James Calvin bought $101,400 worth of Common (4,000 units at $25.35), increasing direct ownership by 16% to 28,661 units (SEC Form 4)

    4 - WEYERHAEUSER CO (0000106535) (Issuer)

    2/20/26 7:35:35 PM ET
    $WY
    Real Estate Investment Trusts
    Real Estate

    Director Beckwitt Richard bought $514,000 worth of Common (20,000 units at $25.70), increasing direct ownership by 492% to 24,066 units (SEC Form 4)

    4 - WEYERHAEUSER CO (0000106535) (Issuer)

    2/20/26 7:00:16 PM ET
    $WY
    Real Estate Investment Trusts
    Real Estate

    $ATI
    $AWI
    $BMY
    $GE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Weyerhaeuser Company

    SC 13G/A - WEYERHAEUSER CO (0000106535) (Subject)

    11/14/24 1:22:34 PM ET
    $WY
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13G/A filed by GE Aerospace

    SC 13G/A - GENERAL ELECTRIC CO (0000040545) (Subject)

    11/12/24 12:54:20 PM ET
    $GE
    Consumer Electronics/Appliances
    Technology

    SEC Form SC 13G filed by ATI Inc.

    SC 13G - ATI INC (0001018963) (Subject)

    11/12/24 9:50:13 AM ET
    $ATI
    Steel/Iron Ore
    Industrials

    $ATI
    $AWI
    $BMY
    $GE
    Financials

    Live finance-specific insights

    View All

    Armstrong World Industries Schedules First-Quarter 2026 Earnings Release and Conference Call

    Armstrong World Industries, Inc. (NYSE:AWI), an Americas leader in the design and manufacture of innovative interior and exterior architectural applications including ceilings, specialty walls and exterior metal solutions, will release its first-quarter 2026 results before the market opens on Tuesday, April 28 and host a conference call to discuss these results at 10:00 a.m. ET. A live webcast of the conference call and the accompanying presentation will be available on the Investor Relations page at Armstrong.com. Attendees who will not be asking a question during the call are encouraged to connect to the live webcast using the Listen Only link below. Those wishing to participate by te

    4/7/26 8:00:00 AM ET
    $AWI
    Plastic Products
    Industrials

    ATI Announces Webcast for First Quarter 2026 Results

    DALLAS, April 2, 2026 /PRNewswire/ -- ATI (NYSE: ATI) has scheduled the live webcast for its first quarter 2026 earnings conference call on Thursday, April 30, 2026, at 7:30 a.m. CT (8:30 a.m. ET).  First Quarter 2026 results are scheduled to be published prior to the call at 6:30 a.m. CT (7:30 a.m. ET). The conference call will be broadcast, and accompanying presentation slides will be available, at ATImaterials.com. To access the broadcast, visit ATImaterials.com and select "Conference Call." The conference call replay will be available on ATImaterials.com.ATI: Proven to Perfo

    4/2/26 8:30:00 AM ET
    $ATI
    Steel/Iron Ore
    Industrials

    Weyerhaeuser to Release First Quarter Results on April 30

    Webcast and conference call on May 1 at 7 a.m. PT (10 a.m. ET)SEATTLE, March 26, 2026 /PRNewswire/ -- Weyerhaeuser Company (NYSE:WY) will release first quarter 2026 results on Thursday, April 30, after the market closes. The company will then hold a live webcast and conference call the following day, on Friday, May 1, at 7 a.m. Pacific (10 a.m. Eastern), to discuss the results. To access the earnings release, live webcast and presentation online, visit the Investors section on www.weyerhaeuser.com.To join the conference call from within North America, dial 877-407-0792 (access c

    3/26/26 4:30:00 PM ET
    $WY
    Real Estate Investment Trusts
    Real Estate

    $ATI
    $AWI
    $BMY
    $GE
    Leadership Updates

    Live Leadership Updates

    View All

    Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

    WALTHAM, Mass., April 20, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced the appointment of Felecia W. Ettenberg, a seasoned leader with more than 25 years of legal experience in the biopharmaceutical industry, as Chief Legal Officer (CLO). She will oversee Ardelyx's legal, compliance, regulatory, and government affairs operations. Ms. Ettenberg succeeds Elizabeth Grammer, who has chosen to retire after an extraordinary 16-year career at the company. "I am thrilled to welcome Felecia as our new Chief Legal Officer," said Mik

    4/20/26 8:00:00 AM ET
    $ARDX
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Companies Unveiling Autonomous Defense System Amid Surge Toward $43 Billion Global Market

    Integrated AI system empowers forces to detect, decide, and deploy faster than traditional command structuresNEW YORK, March 30, 2026 /CNW/ -- Market News Updates News Commentary - Autonomous systems are transforming defense operations by enabling militaries to conduct missions with reduced human intervention, increased precision, and faster decision-making cycles. These systems include unmanned aerial vehicles (UAVs), ground robots, maritime platforms, and AI-enabled command systems that support intelligence, surveillance, reconnaissance (ISR), and combat roles. Their integration is largely driven by advancements in artificial intelligence, sensor fusion, and real-time data processing, allo

    3/30/26 8:45:00 AM ET
    $GE
    $KTOS
    $PDYN
    Consumer Electronics/Appliances
    Technology
    Military/Government/Technical
    Industrials

    Armstrong World Industries Expands Architectural Specialties Design and Fabrication Capabilities with Acquisition of Eventscape, Inc.

    Armstrong World Industries. Inc. (NYSE:AWI), an Americas leader in the design and manufacture of innovative interior and exterior architectural applications including ceilings, specialty walls and exterior metal solutions, announced today that it has acquired Eventscape, Inc., a globally recognized design and fabrication company known for delivering complex, design-driven architectural environments. Based in New York City and Toronto, Canada, Eventscape specializes in the design, fabrication and installation of high-design, complex architectural features for multiple applications including ceilings, feature walls and facades. "We are thrilled to welcome Eventscape to the Armstrong family

    2/19/26 8:05:00 AM ET
    $AWI
    Plastic Products
    Industrials